09/14/2022
3:08 PM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/02/2022
3:36 PM | BioCryst Pharmaceuticals (Issuer)
MILANO VINCENT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/02/2022
3:34 PM | BioCryst Pharmaceuticals (Issuer)
LEVIN ALAN G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/02/2022
3:31 PM | BioCryst Pharmaceuticals (Issuer)
INGRAM ROBERT ALEXANDER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/02/2022
3:29 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/31/2022
3:32 PM | BioCryst Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/25/2022
6:03 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/04/2022
6:06 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2022
3:35 PM | BioCryst Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/09/2022
3:53 PM | BioCryst Pharmaceuticals (Issuer)
SANDERS MACHELLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/09/2022
3:51 PM | BioCryst Pharmaceuticals (Issuer)
MILANO VINCENT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2022
3:50 PM | BioCryst Pharmaceuticals (Issuer)
INGRAM ROBERT ALEXANDER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2022
3:48 PM | BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2022
3:46 PM | BioCryst Pharmaceuticals (Issuer)
McKee Amy E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2022
3:45 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2022
3:43 PM | ABERCROMBIE GEORGE B (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2022
3:41 PM | BioCryst Pharmaceuticals (Issuer)
LEVIN ALAN G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2022
3:40 PM | BioCryst Pharmaceuticals (Issuer)
LEE KENNETH B JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2022
3:38 PM | BioCryst Pharmaceuticals (Issuer)
Galson Steven K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2022
3:36 PM | ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2022
3:43 PM | ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2022
3:34 PM | BioCryst Pharmaceuticals (Issuer)
INGRAM ROBERT ALEXANDER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2022
6:00 AM | BioCryst Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/05/2022
6:05 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2022
3:31 PM | BioCryst Pharmaceuticals (Filer)
| Form DEFA14A
| |
04/25/2022
3:30 PM | BioCryst Pharmaceuticals (Filer)
| Form DEF 14A
| |
09/20/2021
6:06 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/02/2021
3:30 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/02/2021
3:28 PM | ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2021
6:04 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2021
6:05 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2021
6:34 AM | BioCryst Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2021
6:23 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2021
6:06 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/28/2021
5:31 PM | BioCryst Pharmaceuticals (Issuer)
MILANO VINCENT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2021
5:26 PM | BioCryst Pharmaceuticals (Issuer)
MILANO VINCENT (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/28/2021
6:09 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2021
3:39 PM | ABERCROMBIE GEORGE B (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2021
6:06 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/01/2021
3:33 PM | BioCryst Pharmaceuticals (Issuer)
Sheridan William P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2021
3:24 PM | BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2021
3:18 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2021
3:39 PM | BioCryst Pharmaceuticals (Issuer)
LEVIN ALAN G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2021
3:33 PM | BioCryst Pharmaceuticals (Issuer)
LEE KENNETH B JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2021
3:28 PM | BioCryst Pharmaceuticals (Issuer)
INGRAM ROBERT ALEXANDER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2021
3:24 PM | BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2021
3:21 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2021
3:16 PM | ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2021
3:11 PM | ABERCROMBIE GEORGE B (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2021
3:26 PM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
05/26/2021
3:12 PM | ABERCROMBIE GEORGE B (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2021
8:45 AM | BioCryst Pharmaceuticals (Filer)
BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2021
6:09 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2021
6:09 AM | BioCryst Pharmaceuticals (Filer)
BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2021
9:57 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/14/2021
7:21 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2021
8:36 AM | BioCryst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A
| |
04/02/2021
4:26 PM | BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2021
1:02 PM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2021
7:07 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2021
3:41 PM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/02/2021
3:53 PM | BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2021
3:50 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2021
3:47 PM | ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2021
6:07 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2021
8:19 AM | BioCryst Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/25/2021
3:40 PM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2021
6:05 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/24/2021
3:34 PM | BioCryst Pharmaceuticals (Issuer)
Sheridan William P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2021
3:25 PM | Babu Yarlagadda S (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2021
2:16 PM | BioCryst Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A
| |
02/11/2021
11:54 AM | BioCryst Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A
| |
02/10/2021
3:28 PM | BioCryst Pharmaceuticals (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
| Form SC 13G/A
| |
02/05/2021
10:42 AM | BioCryst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G
| |
02/03/2021
6:06 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2021
3:43 PM | BioCryst Pharmaceuticals (Subject)
Sarissa Capital Management LP (Filed by)
| Form SC 13G
| |
01/22/2021
6:12 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2020
7:16 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2020
6:03 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/21/2020
6:05 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2020
3:45 PM | BioCryst Pharmaceuticals (Issuer)
Sniecinski Megan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2020
3:41 PM | BioCryst Pharmaceuticals (Issuer)
Jones Michael L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2020
3:37 PM | BioCryst Pharmaceuticals (Issuer)
Gayer Charles K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2020
3:32 PM | Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2020
3:30 PM | Babu Yarlagadda S (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2020
3:27 PM | BioCryst Pharmaceuticals (Issuer)
Sheridan William P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2020
3:23 PM | BioCryst Pharmaceuticals (Issuer)
Doyle Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2020
3:20 PM | BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2020
4:35 PM | Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2020
6:14 AM | BioCryst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A
| |
12/08/2020
3:12 PM | Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2020
3:24 PM | BioCryst Pharmaceuticals (Issuer)
Jones Michael L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2020
3:23 PM | BioCryst Pharmaceuticals (Issuer)
Sheridan William P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2020
3:21 PM | Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2020
3:19 PM | Babu Yarlagadda S (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2020
3:16 PM | BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2020
8:34 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2020
8:34 AM | BioCryst Pharmaceuticals (Filer)
BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/02/2020
3:21 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2020
3:19 PM | ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
